Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Fingolimod Capsules 0.5 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Fingolimod Capsules 0.5 mg.".